StockWatch
·
Biotechnology
Quarterly Result13 Jul 2026, 07:50 pm

Vivo Bio Tech Declares Q1 FY27 Unaudited Financial Results

AI Summary

Vivo Bio Tech Ltd announced the outcome of its board meeting held on July 13, 2026. The board considered and approved the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The results were reviewed by statutory auditors M/s. P. Murali & Co. The meeting commenced at 7:00 p.m. and concluded at 7:30 p.m. Detailed financial statements along with the limited review report are enclosed.

Key Highlights

  • Board approved unaudited standalone and consolidated financial results.
  • Financial results are for the first quarter ended June 30, 2026.
  • Results were subject to a limited review by statutory auditors.
  • Board meeting held on July 13, 2026.